Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pds Biotechnology Corp (PDSB)

Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults

/CNW/ -- USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale...

ONCY : 1.0100 (unch)
TCRX : 6.86 (-7.80%)
BMY : 40.83 (-0.34%)
PDSB : 2.75 (+3.00%)
CCCC : 4.01 (-3.14%)
ONC.TO : 1.40 (+0.72%)
Global Efforts Intensify to Address Surging Young Adult Colorectal and Anal Cancer Rates

USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale Medicine. As well, there are now alarming reports around...

ONCY : 1.0100 (unch)
ONC.TO : 1.40 (+0.72%)
TCRX : 6.86 (-7.80%)
BMY : 40.83 (-0.34%)
PDSB : 2.75 (+3.00%)
CCCC : 4.01 (-3.14%)
S&P Futures Tick Higher Ahead of Key U.S. Inflation Data, U.S. Debt-Ceiling Talks in Focus

June S&P 500 futures (ESM23) are trending up +0.17% this morning after the S&P 500 and Nasdaq 100 closed sharply higher on Thursday as blowout guidance from Nvidia and progress on debt ceiling talks boosted...

ESM23 : 4,453.35s (+0.61%)
NVDA : 135.68 (+3.59%)
RL : 180.86 (-1.13%)
BBY : 93.22 (+2.15%)
INTC : 30.56 (-1.36%)
RIO.LN : 5,180.000 (-0.02%)
GPS : 25.89 (-0.42%)
MRVL : 73.19 (+1.91%)
WDAY : 207.70 (-2.24%)
TLRY : 1.6900 (-0.30%)
PDSB : 2.75 (+3.00%)
MDB : 219.87 (-1.70%)
3 Deeply Undervalued Stocks That Could Double Your Money

These cutting-edge biotech stocks hold tremendous upside potential.

PDSB : 2.75 (+3.00%)
NTLA : 24.96 (-0.83%)
VERV : 5.10 (-3.23%)
PDS Biotech (PDSB) Up on Data From HPV-Positive Cancer Study

A mid-stage study data shows that treatment with PDS Biotech's (PDSB) lead candidate in advanced HPV-positive cancer patients achieved a median overall survival of 21 months.

CANF : 2.74 (-14.64%)
AMLX : 1.6450 (-0.30%)
ACER : 0.6601 (-17.95%)
PDSB : 2.75 (+3.00%)
Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027

Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0450 (-10.89%)
SGEN : 228.74 (-0.07%)
ZLAB : 18.80 (-0.95%)
PDSB : 2.75 (+3.00%)
ILMN : 108.56 (-0.47%)
GILD : 62.72 (-2.41%)
Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027

/PRNewswire/ -- The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing CAGR. Cervical...

ZLAB : 18.80 (-0.95%)
BIOV.CN : 0.0700 (unch)
BVAXF : 0.0450 (-10.89%)
SGEN : 228.74 (-0.07%)
PDSB : 2.75 (+3.00%)
ILMN : 108.56 (-0.47%)
GILD : 62.72 (-2.41%)
PDS Biotech Reports Second Quarter 2022 Financial Results and Provides Business Update

Announced results from two of the ongoing Phase 2 clinical trials of PDS0101 in multiple, difficult-to-treat HPV16-related cancers presented at the...

PDSB : 2.75 (+3.00%)
PDS Biotech Independent Data Monitoring Committee Recommends VERSATILE-002 Trial Continuation without Modifications

Safety evaluation of 43 patients with no grade 3 or higher treatment-related adverse events...

PDSB : 2.75 (+3.00%)
PDS Biotechnology Announces Presentation of Universal Flu Vaccine Preclinical Data at the 41st American Society of Virology Meeting

PDS0202 neutralized multiple strains of influenza and provided protection against infection in preclinical studies...

PDSB : 2.75 (+3.00%)

Barchart Exclusives

After Nvidia and Broadcom, This Could Be the Next Semiconductor Stock to Split
ASML could be poised to follow in the footsteps of Nvidia and Broadcom by announcing a stock split, making its shares more accessible to retail investors. With its high share price and strong growth prospects, will ASML be the next big semiconductor stock to split? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar